Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LillyDirect Foundayo vs LIV by WellNow

LillyDirect Foundayo
Graded #165

Higher grade

vs+4.300000000000004
LIV by WellNow
Graded #262

Lower grade

The verdict

LillyDirect Foundayo takes it — 67.2/100 to 62.9/100.

LillyDirect Foundayo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLillyDirect Foundayo +21
72
51
Dose & formulationLIV by WellNow +14
59
73
Clinical oversightLIV by WellNow +1
78
79
Labs & monitoringEven
52
52
FulfillmentLillyDirect Foundayo +17
80
63
Contract termsEven
55
55
LillyDirect Foundayo · left barLIV by WellNow · right bar

The numbers

MetricLillyDirect FoundayoLIV by WellNow
WeighScore67.2/10062.9/100
GradeCC
Scorecard rank#165#262
SemaglutideNot disclosed$279/mo
TirzepatideNot disclosedNot disclosed
CoverageAll 50 states5 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
LillyDirect Foundayo

Graded #165 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow
LIV by WellNow

Graded #262 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard